Have Heard of a Fast-Track Clinic for Graves’ Orbitopathy Patients: What Is That?
What Can I Expect when Starting a Combined Thyroid-Eye Clinic?
Hegedüs, L.; Brix, T.H. (Odense)
Do the Eyes Care How Euthyroidism Is Obtained and Maintained?
Should the Presence of Graves’ Orbitopathy Restrict Our Use of Radioiodine Therapy?
Management of Mild Graves’ Orbitopathy
Marcocci, C.; Rocchi, R. (Pisa)
Are Mild Forms Likely to Progress to More Severe Graves’ Orbitopathy?
Is a “Wait-and-See” Policy Justified in Patients with Mild Graves’ Orbitopathy?
Are Low-Dosage Oral Steroids Advisable or Is Orbital Radiotherapy Preferable?
What Is the Rationale for Antioxidant Therapy like Selenium in Graves’ Orbitopathy?
Management of Moderately Severe Graves’ Orbitopathy
Kahaly, G.J. (Mainz)
How Is Moderately Severe Graves’ Orbitopathy Defined?
Is Immunosuppression Indicated in Moderately Severe Graves’ Orbitopathy?
What Are the Cellular and Molecular Mechanisms of Steroid Anti-Inflammation and Immunosuppression?
What Are the Results of Randomized Trials with Steroids?
What Are the Results of Randomized Trials Using Orbital Radiotherapy?
Do You Favour Combined Steroid/Radiotherapy?
What Are the Results of Randomized Trials Using Non-Steroid Immunosuppressants?
What Are the Results of Randomized Trials Using Somatostatin Analogues?
How Should a Diabetic or Hypertensive Patient with Moderately Severe Graves’ Orbitopathy Be Treated?
What Should You Do if Steroids Fail?
What Do the ETA/EUGOGO Guidelines for the Management of Graves’ Orbitopathy Recommend?
Novel Immunomodulatory Treatment Modalities
Lane, L.C.; Perros, P.; Pearce, S.H.S. (Newcastle upon Tyne)
Why Look for New Immunomodulatory Treatments?
What Are the Targets for Potential Novel Therapies?
What Are the Most Likely Targets for Therapeutic Intervention?
Should Clinicians Be Cautious about Trying Novel Immunomodulators?
Management of Very Severe Graves’ Orbitopathy: Dysthyroid Optic Neuropathy and Corneal Breakdown
Boschi, A. (Brussels); Currò, N. (Milan)